1. Home
  2. GTLS vs CRL Comparison

GTLS vs CRL Comparison

Compare GTLS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chart Industries Inc.

GTLS

Chart Industries Inc.

HOLD

Current Price

$207.49

Market Cap

9.3B

Sector

Industrials

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$179.54

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTLS
CRL
Founded
1859
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Commercial Physical & Biological Resarch
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
8.3B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
GTLS
CRL
Price
$207.49
$179.54
Analyst Decision
Hold
Buy
Analyst Count
11
13
Target Price
$203.22
$197.58
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,857,601,000.00
Revenue This Year
$8.33
$2.51
Revenue Next Year
$11.45
$4.66
P/E Ratio
$240.25
N/A
Revenue Growth
N/A
10.48
52 Week Low
$104.60
$91.86
52 Week High
$208.24
$228.88

Technical Indicators

Market Signals
Indicator
GTLS
CRL
Relative Strength Index (RSI) 57.69 47.38
Support Level $206.71 $145.97
Resistance Level $207.77 $182.81
Average True Range (ATR) 0.42 9.64
MACD -0.01 1.38
Stochastic Oscillator 80.95 77.01

Price Performance

Historical Comparison
GTLS
CRL

About GTLS Chart Industries Inc.

Chart Industries provides a variety of cryogenic equipment for storage, distribution, and other processes within the industrial gas and liquefied natural gas industries. It also provides natural gas processing solutions for the natural gas industry and specialty products that serve a variety of spaces, including hydrogen, biofuels, cannabis, and water treatment. The firm acquired Howden in a significant deal in early 2023, roughly doubling the size of the company. It plans to merge with Flowserve by the end of 2025.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: